
Novel cardiology therapy for cats is launched
A new therapy for managing ventricular hypertrophy in felines with subclinical hypertrophic cardiomyopathy (HCM) was officially launched Tuesday, June 17, 2025, by PRN Pharmacal, a Pegasus Laboratories brand. The drug, sirolimus delayed-release tablets ( …